Health3 years ago
Mixed bag of IL-6 inhibitor in severe COVID-19
Discussions on the use of interleukin-6 inhibitors, including tocilizumab (Actemra) and sarilumab (Kevzara), in COVID-19 patients may continue. Improved survival. In COVACTA trialNo significant difference in...
Recent Comments